Helix Biotech

Helix Biotech is an active US-based CDMO specializing in the custom synthesis, formulation, and GMP manufacturing of nucleic acids, lipid nanoparticles, liposomes, and hybrid nanoparticles. The company provides end-to-end solutions from early-stage R&D through clinical translation to commercial scale-up. It serves emerging biotech firms as well as established pharmaceutical companies developing nucleic acid-based drugs and other advanced therapies. Its expertise includes encapsulation technology development, analytical testing services, process engineering/design of scalable nanoparticle systems such as NOVA™ IJM and TWIST platforms. Helix does not have its own therapeutic pipeline but enables client programs across multiple modalities by providing critical enabling technologies for drug delivery.